AlphaQ Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,883
Closed -$1.02M 100
2024
Q1
$1.02M Sell
1,883
-50
-3% -$27.3K 0.61% 46
2023
Q4
$1.07M Buy
1,933
+121
+7% +$56.8K 0.74% 37
2023
Q3
$792K Sell
1,812
-65
-3% -$32.4K 0.69% 37
2023
Q2
$943K Sell
1,877
-206
-10% -$98.7K 0.69% 39
2023
Q1
$1.04M Sell
2,083
-14
-0.7% -$6.7K 0.89% 26
2022
Q4
$855K Buy
+2,097
New +$814K 0.74% 40

Other funds holding IDXX

AlphaQ Advisors's IDXX Position: Q2 2024 in Review

AlphaQ Advisors sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 1,883 shares — an estimated $1.02M sold.

AlphaQ Advisors first reported a position in IDXX in Q4 2022 and held it in 6 quarters. The position peaked at $1.07M in Q4 2023. 1,109 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • AlphaQ Advisors reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • AlphaQ Advisors sold 1,883 Idexx Laboratories shares in Q2 2024, an estimated $1.02M.
  • AlphaQ Advisors first reported a position in Idexx Laboratories in Q4 2022 and held it in 6 quarters.
  • AlphaQ Advisors's Idexx Laboratories position peaked at $1.07M in Q4 2023.
  • 1,109 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on AlphaQ Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.